申请人:Gervais Berube
公开号:US20040006051A1
公开(公告)日:2004-01-08
1
wherein n may be 1, 2, 3, 4 or 5 when X is O, wherein n may be 2/3, 1, 4/3, 5/3, 2, 7/3, 8/3, 3, or 10/3 when X is C, wherein o may be 1, 2 or 3, wherein Y may be O or 17&bgr;-OH,
wherein R
1
may be selected from the group consisting of H, a straight alkyl group of 1 to 5 carbon atoms, a branched alkyl group of 3 to 5 carbon atoms,
wherein R
2
may be selected for the group consisting of H, a straight alkyl group of 1 to 4 carbon atoms, a branched alkyl group of 3 or 4 carbon atoms, F, Cl, Br, I, —CF
3
, —NO
2
, —OR
1
, —COR
1
and —CH
2
OH. These compounds possess anticancer activity against hormono-dependent breast, uterus as well as ovarian cancer.
其中,当X为O时,n可以是1、2、3、4或5,当X为C时,n可以是2/3、1、4/3、5/3、2、7/3、8/3、3或10/3,o可以是1、2或3,Y可以是O或17β-OH,R1可以从H、1至5个碳原子的直链烷基或3至5个碳原子的支链烷基中选择,R2可以从H、1至4个碳原子的直链烷基或3或4个碳原子的支链烷基、F、Cl、Br、I、—CF3、—NO2、—OR1、—COR1和—CH2OH中选择。这些化合物对激素依赖性乳腺、子宫和卵巢癌具有抗癌活性。